Fosaprepitant Dimeglumine 150mg Injection

Fosaprepitant Dimeglumine 150mg is an intravenous antiemetic used with other medicines to prevent nausea and vomiting caused by cancer chemotherapy, including delayed symptoms after the treatment day.
After reconstitution and dilution, it is infused into a vein before chemotherapy. It is used with a serotonin-receptor antagonist and usually dexamethasone; the steroid dose is adjusted for the interaction.
Fosaprepitant is converted to aprepitant, which blocks substance P at neurokinin-1 receptors involved in the vomiting reflex.
Headache, hiccups, fatigue and infusion-site irritation can occur. Severe hypersensitivity and significant infusion-site reactions are important risks.
Warfarin and several CYP3A-interacting medicines need review. Hormonal contraception may be less reliable during treatment and for a period afterwards, so additional non-hormonal protection is needed.
Adds protection against delayed vomiting when used as part of a multi-drug antiemetic regimen.
Its main role is prevention around chemotherapy. Breakthrough vomiting may need an additional rescue antiemetic.
They block different vomiting pathways and provide broader protection than one medicine alone.
Not in every regimen. A single-dose fosaprepitant schedule can replace a multi-day oral aprepitant schedule.
Aprepitant increases dexamethasone exposure, so antiemetic regimens account for that interaction.
Antiemetic: a medicine that prevents or reduces vomiting. NK1 receptor: a receptor activated by substance P. Delayed nausea: nausea occurring after the first 24 hours of chemotherapy.; AR: Fosaprepitant Dimeglumine 150mg حقن; FR: Fosaprepitant Dimeglumine 150mg injection; PT: Fosaprepitant Dimeglumine 150mg injeção; ES: Fosaprepitant Dimeglumine 150mg inyección; RU: Fosaprepitant Dimeglumine 150mg инъекция; ID: Fosaprepitant Dimeglumine 150mg suntikan; VI: Fosaprepitant Dimeglumine 150mg thuốc tiêm; MS: Fosaprepitant Dimeglumine 150mg suntikan; TL: Fosaprepitant Dimeglumine 150mg iniksyon; ZH-SG: Fosaprepitant Dimeglumine 150mg 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Fosaprepitant Dimeglumine 150mg Injection under Digestive Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Fosaprepitant Dimeglumine 150mg Injection